Get the Stockscreener App
0.00
100.00%
-19.94
After Hours:
19.05
19.05
+
Calliditas Therapeutics AB ADR Stock (CALT) Forecast
The Calliditas Therapeutics AB ADR (CALT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $36.70, representing a + increase from the current price of $0.00. The highest analyst price target is $44.10, and the lowest is $29.31.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CALT Price Target
Average 35.53
(+ Upside)
Is Calliditas Therapeutics AB ADR (CALT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 15.35 | Buy |
| STOCH(9,6) | 58.21 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -2.1066 | Sell |
| ADX(14) | 19.13 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -466.67 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
16.87
Sell
|
15.68
Sell
|
| MA20 |
18.70
Sell
|
17.73
Sell
|
| MA50 |
20.40
Sell
|
19.68
Sell
|
| MA100 |
21.56
Sell
|
20.23
Sell
|
| MA200 |
19.47
Sell
|
20.21
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CALT could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CALT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 15.35 indicates that CALT is oversold. This indicates that CALT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 58.21 indicates that CALT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that CALT is oversold. This suggests that CALT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.13 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -466.67 indicates that CALT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CALT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Calliditas Therapeutics AB ADR financial reports and earnings history, Calliditas Therapeutics AB ADR (CALT) stock could reach $34.43 by 2030, $57.88 by 2040 and $69.93 by 2050. See the projected annual prices until 2050 of the Calliditas Therapeutics AB ADR stock below:
- Calliditas Therapeutics AB ADR (CALT) is expected to reach an average price of $40.25 in 2035, with a high prediction of $42.89 and a low estimate of $38.57. This indicates an $ rise from the last recorded price of $0.00.
- Calliditas Therapeutics AB ADR (CALT) stock is projected to chart a bullish course in 2040, with an average price target of $49.00, representing an $ surge from its current level. The forecast ranges from a conservative $47.71 to a sky-high $57.88.
- Our analysts predict Calliditas Therapeutics AB ADR (CALT) to jump by 2045, soaring from $64.52 to an average price of $66.21, potentially reaching $66.55. While $64.52 is the low estimate, the potential upside is significant.
- Calliditas Therapeutics AB ADR (CALT) stock is expected to climb by 2050, reaching an average of $63.45, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $69.93 and $63.33, respectively, highlighting the market's uncertainty.
Calliditas Therapeutics AB ADR Stock (CALT) Year by Year Forecast
Calliditas Therapeutics AB ADR Stock (CALT) Price Forecast for 2024
Our forecast for CALT stock price in 2024 now indicates an average price target of $34.50 with a high forecast of $44.10 and a low forecast of $24.90. The average prediction reflects an increase of + from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $38.64 | $29.31 | $44.10 | + |
| July, 2024 | $39.63 | $37.93 | $42.77 | + |
| August, 2024 | $37.77 | $37.52 | $40.91 | + |
| September, 2024 | $38.61 | $33.21 | $39.37 | + |
| October, 2024 | $36.19 | $32.74 | $38.71 | + |
| November, 2024 | $33.85 | $33.25 | $36.35 | + |
| December, 2024 | $34.36 | $33.02 | $38.16 | + |
Calliditas Therapeutics AB ADR Stock (CALT) Price Forecast for 2025
Calliditas Therapeutics AB ADR Stock (CALT) is expected to reach an average price of $30.22 in 2025, with a high prediction of $39.60 and a low estimate of $20.85. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $35.80 | $33.06 | $37.28 | + |
| February, 2025 | $35.84 | $34.04 | $38.24 | + |
| March, 2025 | $35.48 | $34.95 | $39.60 | + |
| April, 2025 | $30.38 | $26.96 | $39.37 | + |
| May, 2025 | $29.56 | $28.20 | $38.73 | + |
| June, 2025 | $28.72 | $26.68 | $29.99 | + |
| July, 2025 | $23.56 | $21.53 | $29.68 | + |
| August, 2025 | $23.77 | $22.97 | $26.48 | + |
| September, 2025 | $29.88 | $20.85 | $34.13 | + |
| October, 2025 | $27.90 | $25.29 | $31.44 | + |
| November, 2025 | $25.22 | $23.06 | $29.71 | + |
| December, 2025 | $25.76 | $21.80 | $26.78 | + |
Calliditas Therapeutics AB ADR Stock (CALT) Price Forecast for 2026
The predicted value for Calliditas Therapeutics AB ADR (CALT) in 2026 is set at an average of $23.76. Estimates vary from a peak of $29.66 to a trough of $17.87, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $25.11 | $23.78 | $27.65 | + |
| February, 2026 | $21.00 | $19.38 | $25.73 | + |
| March, 2026 | $25.53 | $21.19 | $27.41 | + |
| April, 2026 | $25.26 | $22.66 | $25.89 | + |
| May, 2026 | $25.59 | $23.19 | $26.25 | + |
| June, 2026 | $23.48 | $22.31 | $29.66 | + |
| July, 2026 | $21.36 | $20.70 | $24.52 | + |
| August, 2026 | $21.56 | $17.87 | $24.48 | + |
| September, 2026 | $22.58 | $20.37 | $23.96 | + |
| October, 2026 | $25.68 | $22.28 | $26.85 | + |
| November, 2026 | $26.97 | $22.70 | $28.14 | + |
| December, 2026 | $25.76 | $25.58 | $28.49 | + |
Calliditas Therapeutics AB ADR Stock (CALT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Calliditas Therapeutics AB ADR (CALT) is $28.87, with a high forecast of $34.98 and a low forecast of $22.76. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $25.74 | $24.14 | $27.86 | + |
| February, 2027 | $30.07 | $23.55 | $32.75 | + |
| March, 2027 | $30.65 | $28.36 | $32.80 | + |
| April, 2027 | $25.18 | $24.66 | $32.96 | + |
| May, 2027 | $25.32 | $23.93 | $26.51 | + |
| June, 2027 | $24.02 | $22.76 | $25.24 | + |
| July, 2027 | $26.75 | $24.25 | $27.33 | + |
| August, 2027 | $23.17 | $22.99 | $27.84 | + |
| September, 2027 | $25.88 | $22.76 | $26.90 | + |
| October, 2027 | $23.86 | $23.56 | $26.60 | + |
| November, 2027 | $24.95 | $22.84 | $26.57 | + |
| December, 2027 | $29.91 | $24.85 | $34.98 | + |
Calliditas Therapeutics AB ADR Stock (CALT) Price Forecast for 2028
In 2028, Calliditas Therapeutics AB ADR (CALT) is projected to reach an average price of $40.50, with a high projection of $50.20 and a low estimate of $30.79. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $35.03 | $30.79 | $36.80 | + |
| February, 2028 | $35.58 | $33.00 | $40.27 | + |
| March, 2028 | $34.43 | $32.96 | $37.95 | + |
| April, 2028 | $34.57 | $33.76 | $37.05 | + |
| May, 2028 | $39.88 | $34.38 | $40.74 | + |
| June, 2028 | $37.35 | $35.39 | $44.20 | + |
| July, 2028 | $46.11 | $44.04 | $50.20 | + |
| August, 2028 | $45.95 | $44.73 | $47.06 | + |
| September, 2028 | $39.41 | $39.41 | $45.56 | + |
| October, 2028 | $39.97 | $38.98 | $44.94 | + |
| November, 2028 | $40.11 | $39.53 | $42.89 | + |
| December, 2028 | $40.98 | $39.32 | $41.32 | + |
Calliditas Therapeutics AB ADR Stock (CALT) Price Forecast for 2029
The 2029 price forecast for Calliditas Therapeutics AB ADR Stock (CALT) is $36.74 on average, with a high prediction of $46.01 and a low estimate of $27.48. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $42.30 | $39.40 | $44.47 | + |
| February, 2029 | $41.31 | $40.43 | $44.62 | + |
| March, 2029 | $42.35 | $41.39 | $46.01 | + |
| April, 2029 | $33.95 | $33.42 | $45.82 | + |
| May, 2029 | $43.22 | $34.80 | $45.23 | + |
| June, 2029 | $35.32 | $34.38 | $43.75 | + |
| July, 2029 | $30.87 | $28.10 | $36.53 | + |
| August, 2029 | $31.59 | $29.55 | $33.08 | + |
| September, 2029 | $39.59 | $27.48 | $40.76 | + |
| October, 2029 | $33.11 | $31.97 | $39.44 | + |
| November, 2029 | $32.54 | $32.49 | $36.42 | + |
| December, 2029 | $32.03 | $28.54 | $33.51 | + |
Calliditas Therapeutics AB ADR Stock (CALT) Price Forecast for 2030
Calliditas Therapeutics AB ADR Stock (CALT) is expected to reach an average price of $30.76 in 2030, with a high forecast of $36.61 and a low forecast of $24.92. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $33.19 | $31.14 | $34.43 | + |
| February, 2030 | $27.82 | $27.34 | $33.05 | + |
| March, 2030 | $31.56 | $26.21 | $33.94 | + |
| April, 2030 | $31.54 | $29.54 | $34.28 | + |
| May, 2030 | $32.05 | $30.11 | $32.45 | + |
| June, 2030 | $30.06 | $30.03 | $36.61 | + |
| July, 2030 | $29.84 | $29.01 | $31.52 | + |
| August, 2030 | $29.68 | $27.72 | $31.51 | + |
| September, 2030 | $29.41 | $24.92 | $30.66 | + |
| October, 2030 | $32.23 | $28.78 | $33.95 | + |
| November, 2030 | $31.30 | $29.85 | $35.28 | + |
| December, 2030 | $33.58 | $31.40 | $35.35 | + |
3.18%
Cap:
|
Volume (24h):